hotspot -WSS

hotspot

author：fashion 2025-10-02 12:41:55 - browse：383

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Resistance to opioid

WSS

How to convince healthy people to buy insurance

Key Senate panel to consider PBM, drug pricing reform package

Doctors on social media are being harassed and cyberbullied

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Congress considering partial increase for doctor pay in Medicare

hotspot

hotspot

focus

Hepatitis C has a cure — but many Americans still lack access to it

How neuroscience research could help beat back brain cancer

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Juul documents reveal insider tactics on political lobbying

As demand for Covid shots wanes, Moderna seeks its next success

How to convince healthy people to buy insurance

In Memoriam: Notable people who died in 2023

Bill would allow buprenorphine prescription for addiction via telehealth

Virginia high school admissions case could be legal follow

Congress might make insulin pumps more accessible to the blind

entertainment

How neuroscience research could help beat back brain cancer

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Doctors on social media are being harassed and cyberbullied

Doctors on social media are being harassed and cyberbullied

Latigo launches with $135 million for Vertex

Explaining an after

hotspot

hotspot

leisure time

explore